Primary Site >> Colorectal Cancer

Gene >> CDK9

Journal: Mol Pharmacol. 2003 Nov;64(5):1101-8.
Title: Acquired cellular resistance to flavopiridol in a human colon carcinoma cell line involves up-regulation of the telomerase catalytic subunit and telomere elongation. Sensitivity of resistant cells to combination treatment with a telomerase inhibitor.
Author: Incles, Christopher M|Schultes, Christoph M|Kelland, Lloyd R|Neidle, Stephen
PMID: 14573759
Journal: Cancer Res. 2004 Jan 1;64(1):262-72.
Title: The Cyclin-dependent kinase inhibitor CYC202 (R-roscovitine) inhibits retinoblastoma protein phosphorylation, causes loss of Cyclin D1, and activates the mitogen-activated protein kinase pathway.
Author: Whittaker, Steven R|Walton, Mike I|Garrett, Michelle D|Workman, Paul
PMID: 14729633
Journal: Cancer Res. 2007 Sep 1;67(17):8325-34.
Title: Meriolins, a new class of cell death inducing kinase inhibitors with enhanced selectivity for cyclin-dependent kinases.
Author: Bettayeb, Karima|Tirado, Oscar M|Marionneau-Lambot, Severine|Ferandin, Yoan|Lozach, Olivier|Morris, Jonathan C|Mateo-Lozano, Silvia|Drueckes, Peter|Schachtele, Christoph|Kubbutat, Michael H G|Liger, Francois|Marquet, Bernard|Joseph, Benoit|Echalier, Aude|
PMID: 17804748
Journal: Cancer Res. 2008 Apr 1;68(7):2312-20.
Title: The cyclin-dependent kinase inhibitor flavopiridol potentiates the effects of topoisomerase I poisons by suppressing Rad51 expression in a p53-dependent manner.
Author: Ambrosini, Grazia|Seelman, Sharon L|Qin, Li-Xuan|Schwartz, Gary K
PMID: 18381438
Journal: Cancer Prev Res (Phila). 2009 Sep;2(9):800-6.
Title: Chemoprevention of mouse intestinal tumorigenesis by the cyclin-dependent kinase inhibitor SNS-032.
Author: Boquoi, Amelie|Chen, Tina|Enders, Greg H
PMID: 19723896
Journal: Bioorg Med Chem. 2011 Nov 15;19(22):6949-65.
Title: Design, synthesis and biological evaluation of 6-pyridylmethylaminopurines as CDK inhibitors.
Author: Wilson, Stuart C|Atrash, Butrus|Barlow, Clare|Eccles, Susan|Fischer, Peter M|Hayes, Angela|Kelland, Lloyd|Jackson, Wayne|Jarman, Michael|Mirza, Amin|Moreno, Javier|Nutley, Bernard P|Raynaud, Florence I|Sheldrake, Peter|Walton, Mike|Westwood, Robert|Whitta
PMID: 21982796
Journal: Eur J Med Chem. 2012 Nov;57:311-22.
Title: Synthesis and biological evaluation of imidazo[4,5-b]pyridine and 4-heteroaryl-pyrimidine derivatives as anti-cancer agents.
Author: Lukasik, Pawel M|Elabar, Sherifa|Lam, Frankie|Shao, Hao|Liu, Xiangrui|Abbas, Abdullah Y|Wang, Shudong
PMID: 23085105
Journal: J Biol Regul Homeost Agents. 2015 Oct-Dec;29(4):823-8.
Title: The profile of melatonin receptors gene expression and genes associated with their activity in colorectal cancer: a preliminary report.
Author: Ziolko, E|Kokot, T|Skubis, A|Sikora, B|Szota-Czyz, J|Kruszniewska-Rajs, C|Wierzgon, J|Mazurek, U|Grochowska-Niedworok, E|Muc-Wierzgon, M
PMID: 26753642
Journal: Drug Resist Updat. 2017 Nov;33-35:36-42.
Title: TAK-ing aim at chemoresistance: The emerging role of MAP3K7 as a target for cancer therapy.
Author: Santoro, Raffaela|Carbone, Carmine|Piro, Geny|Chiao, Paul J|Melisi, Davide
PMID: 29145973
Journal: Mol Oncol. 2018 Mar;12(3):287-304.
Title: Molecular profiling and combinatorial activity of CCT068127: a potent CDK2 and CDK9 inhibitor.
Author: Whittaker, Steven R|Barlow, Clare|Martin, Mathew P|Mancusi, Caterina|Wagner, Steve|Self, Annette|Barrie, Elaine|Te Poele, Robert|Sharp, Swee|Brown, Nathan|Wilson, Stuart|Jackson, Wayne|Fischer, Peter M|Clarke, Paul A|Walton, Michael I|McDonald, Edward|Bla
PMID: 29063678
Journal: Mol Cell Biol. 2018 May 15;38(11). pii: MCB.00573-17.
Title: Depletion of Mediator Kinase Module Subunits Represses Superenhancer-Associated Genes in Colon Cancer Cells.
Author: Kuuluvainen, Emilia|Domenech-Moreno, Eva|Niemela, Elina H|Makela, Tomi P
PMID: 29507187
Journal: Mol Cancer Ther. 2018 Jun;17(6):1156-1166.
Title: ICEC0942, an Orally Bioavailable Selective Inhibitor of CDK7 for Cancer Treatment.
Author: Patel, Hetal|Periyasamy, Manikandan|Sava, Georgina P|Bondke, Alexander|Slafer, Brian W|Kroll, Sebastian H B|Barbazanges, Marion|Starkey, Richard|Ottaviani, Silvia|Harrod, Alison|Aboagye, Eric O|Buluwela, Laki|Fuchter, Matthew J|Barrett, Anthony G M|Coombe
PMID: 29545334
Journal: Eur J Med Chem. 2018 Sep 13;158:896-916.
Title: Discovery of 4-(((4-(5-chloro-2-(((1s,4s)-4-((2-methoxyethyl)amino)cyclohexyl)amino)pyridin-4- yl)thiazol-2-yl)amino)methyl)tetrahydro-2H-pyran-4-carbonitrile (JSH-150) as a novel highly selective and potent CDK9 kinase inhibitor.
Author: Wang, Beilei|Wu, Jiaxin|Wu, Yun|Chen, Cheng|Zou, Fengming|Wang, Aoli|Wu, Hong|Hu, Zhenquan|Jiang, Zongru|Liu, Qingwang|Wang, Wei|Zhang, Yicong|Liu, Feiyang|Zhao, Ming|Hu, Jie|Huang, Tao|Ge, Juan|Wang, Li|Ren, Tao|Wang, Yuxin|Liu, Jing|Liu, Qingsong
PMID: 30253346